Silencing PRDM14 expression by an innovative RNAi therapy inhibits stemness, tumorigenicity, and metastasis of breast cancer.

about

PRDM14 directly interacts with heat shock proteins HSP90α and glucose-regulated protein 78.PRDM14 is overexpressed in chronic pancreatitis prior to pancreatic cancer

P2860

Q47311590-59617305-BFCF-4DAC-A2CF-E61B1B7B1A70 Q58554308-AAEB26D4-8B5A-42DF-99C4-A35991622A82

P2860

Silencing PRDM14 expression by an innovative RNAi therapy inhibits stemness, tumorigenicity, and metastasis of breast cancer.

Item

http://www.wikidata.org/entity/Q41470786

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Silencing PRDM14 expression by ...... d metastasis of breast cancer.

@en

type

Item

label

Silencing PRDM14 expression by ...... d metastasis of breast cancer.

@en

prefLabel

Silencing PRDM14 expression by ...... d metastasis of breast cancer.

@en

P1476

Silencing PRDM14 expression by ...... nd metastasis of breast cancer

@en

P2093

Daisuke Hoshino

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Yamamoto

http://www.w3.org/2001/XMLSchema#string

Hitoshi Zembutsu

http://www.w3.org/2001/XMLSchema#string

Kazunori Kataoka

http://www.w3.org/2001/XMLSchema#string

Kohzoh Imai

http://www.w3.org/2001/XMLSchema#string

Nobuhiro Nishiyama

http://www.w3.org/2001/XMLSchema#string

P2860

The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors

CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

Efficient tumour formation by single human melanoma cells

Prospective identification of tumorigenic breast cancer cells

The Polycomb group protein Eed protects the inactive X-chromosome from differentiation-induced reactivation.

A bivalent chromatin structure marks key developmental genes in embryonic stem cells

Molecular definition of breast tumor heterogeneity

A mesodermal factor, T, specifies mouse germ cell fate by directly activating germline determinants

Critical appraisal of the side population assay in stem cell and cancer stem cell research

P304

46856-46874

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.16776

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hiroaki Taniguchi

Chiharu Moriya

P577

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28423353

http://www.w3.org/2001/XMLSchema#string

P932

5564528

http://www.w3.org/2001/XMLSchema#string

Silencing PRDM14 expression by an innovative RNAi therapy inhibits stemness, tumorigenicity, and metastasis of breast cancer.

about

P2860

P2860

Silencing PRDM14 expression by an innovative RNAi therapy inhibits stemness, tumorigenicity, and metastasis of breast cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932